Emami Q2 FY26 Earnings Call Transcript: GST Impact & Future Outlook
Emami's Q2 FY26 earnings call reveals a revenue dip due to GST impact, offset by growth in specific portfolios, relaunch of Kesh King, and optimism for a strong second half with a dividend declared.
The GST impact and strategic changes have a medium impact on the company's performance and future outlook.
The announcement discusses both positive and negative aspects, including revenue decline and growth in specific segments, resulting in a neutral sentiment.
* Emami Limited's Q2 FY26 earnings call transcript discusses the impact of GST rate reductions and future strategies. * Consolidated revenues declined by 10% to ₹799 crore, with a 15% decline in domestic business due to GST-related trade disruptions and heavy rains affecting summer portfolio sales. * Excluding GST-affected categories, the portfolio showed encouraging growth, with the Medico range up by 8%, Zandu cough syrup by 43%, Honey by 36%, and Zandu Care growing by 17%. * Strategic investment portfolios rebounded with a 16% year-on-year growth and 36% sequentially. * The company relaunched Kesh King as Kesh King Gold, combining Ayurveda with science, and launched 12 new products under Smart and Handsome. * International business grew by 8% despite macro and geopolitical headwinds. * Gross margins remained stable at 71%, but EBITDA declined by 29% to ₹179 crore, and PAT declined by 30% to ₹148 crore. * An interim dividend of 400%, amounting to ₹4 per share for FY26, was declared. * October witnessed a healthy rebound in trade sentiments, with deferred winter loading being recovered. * The company is optimistic about a robust and profitable second half, supported by a favorable winter season and normalization of trade post-GST reform. * Management anticipates close to double-digit growth in Q3, driven by recovery in GST-impacted portfolios and winter loading. * The company expects benefits from the GST rate cut to continue, with potential for new consumers from the unorganized sector.
What to do with a filing like this
Emami Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Emami Limited. Read the original for the full detail.